SINGAPORE'S Novena Global Healthcare has bagged US$20 million in investment from Sinopharm Capital and Cedarlake Capital Group.
The US$20 million investment will be used to grow the Singapore aesthetic healthcare firm's existing business in China and South-east Asia. This is while leveraging on Sinopharm Capital’s network and resources for its China expansion. Nelson Loh, executive chairman and co-founder of DORR Group and Novena Global Lifecare, said the company will continue to innovate and disrupt the lifecare industry around the region.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Singapore businesses 'moderately optimistic' on growth amid global economic slowdown: Korn Ferry pollGLOBAL macro factors and talent shortage are the top external factors that will impact overall business performance for Singapore firms in the coming year, according to a survey by management consultant firm Korn Ferry. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
China tells top global CEOs it will 'further open up'CHINESE Premier Li Keqiang vowed on Thursday to further open up China's economy during a meeting with CEOs of top global companies amid simmering trade tensions with the United States. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Growth in global financial wealth screeched to a halt in 2018[NEW YORK] Gains in global personal wealth ground to a near-halt in 2018, rising just 1.6 per cent for the weakest growth in five years. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »